Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis e

Journal of Viral Hepatitis

Volumn 21, Issue 2, 2014, Pages 141-151

  Rathod, S B ^a   Das, R ^a   Thanapati, S ^a   Arankalle, V A ^a   Tripathy, A S ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

CFSE; Conventional phenotypes markers; Foxp3 mRNA; Functional Treg cells; Teff cells

Indexed keywords

5' NUCLEOTIDASE; CD103 ANTIGEN; CELL MARKER; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE HEPATITIS; ACUTE HEPATITIS E; ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; YOUNG ADULT; BIOSYNTHESIS; BLOOD; GENE EXPRESSION PROFILING; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPHENOTYPING; PHYSIOLOGY;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; HEPATITIS E; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INTERLEUKIN-10; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84891826297     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12125     Document Type: Article

References (36)

1. Aggarwal R, Krawczynski K,. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000; 15: 9-20.
2. Mushahwar I,. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology and prevention. J Med Virol 2008; 80: 646-658.
3. Naik S, Aggarwal R, Naik SR, et al,. Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J Gastroenterol 2002; 21: 149-152.
4. Tripathy AS, Das R, Rathod SB, Gurav YK, Arankalle VA,. Peripheral T regulatory cells and cytokines in hepatitis E infection. Eur J Clin Microbiol Infect Dis 2012; 31: 179-184.
5. high regulatory T cells in acute dengue infection. J Exp Med 2007; 204: 979-985.
6. Saravanabalaji S, Tripathy AS, Dhoot RR, Chadha MS, Kakrani AL, Arankalle VA,. Viral load, antibody titers and recombinant open reading frame 2 protein- induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E. Intervirol 2009; 52: 78-85.
7. Belkaid Y, Tarbell K,. Regulatory T cells in the control of host-microorganism interactions. Ann Rev Immunol 2009; 27: 551-589.
8. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
9. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
10. Collison LW, Workman CJ, Kuo TT, et al,. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450: 566-569.
11. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J Immunol 2004; 172: 5213-5221.
12. + Treg cells in chronic HCV infected-patients. Virol J 2011; 8: 279.
13. Hi regulatory T cells. Int Immunol 2009; 21: 1065-1077.
14. Deaglio S, Dwyer KM, Gao W, et al,. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-1265.
15. Arankalle VA, Lole KS, Deshmukh TM, Chobe LP, Gandhe SS,. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections. J Viral Hepat 2007; 14: 435-445.
16. Tripathy AS, Das R, Rathod SB, Arankalle VA,. Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection. PLoS One 2012; 7: e31822.
17. Quah BJC, Parish CR,. The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation. J Vis Exp 2010; 44: e2259.
18. Moritz Peiseler, Marcial Sebode, Björn Franke,. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatolol 2012; 57: 125-132.
19. Katara GK, Ansari NA, Verma S, Ramesh V, Salotra P,. Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis 2011; 5: e1171.
20. Maloy KJ, Powrie F,. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816-822.
21. + T cells that prevent spontaneous autoimmune encephalomyelitis. J Immunol 2000; 164: 5499-5507.
22. Yasutomo K, Lucas B, Germain RN,. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type. J Immunol 2000; 165: 3015-3022.
23. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001; 166: 3008-3018.
24. Srivastava R, Aggarwal R, Jameel S, et al,. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 proteins. Viral Immunol 2007; 20: 56-65.
25. Perrella A, Atripaldi L, Racioppi L, et al,. Elevated CD4+/CD25+ regulatory T cell number and function during acute hepatitis C, presage chronic evolution. Gut 2006; 55: 1370-1371.
26. high regulatory T cells during acute hepatitis C virus infection. J Infect Dis 2008; 197: 46-57.
27. + regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007; 19: 133-140.
28. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
29. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149-5153.
30. Suneetha PV, Pischke S, Schlaphoff V, et al,. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatol 2012; 55: 695-708.
31. Fortner KA, Budd RC,. The death receptor Fas (CD95/APO-1) mediates the deletion of T lymphocytes undergoing homeostatic proliferation. J Immunol 2005; 175: 4374-4382.
32. Arens R, Baars PA, Jak M, et al,. Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation. J Immunol 2005; 174: 5915-5920.
33. Bouillet P, O'Reilly LA,. CD95, BIM and T cell homeostasis. Nat Rev Immunol 2009; 9: 514-519.
34. + Immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311-323.
35. - regulatory T cells. Proc Natl Acad Sci USA 2002; 99: 13031-13036.
36. + T regulatory cells correlates with progression of HBV infection. BMC Immunol 2012; 13: 17.